Physical Activity, Inactivity and Sleep in Individuals with Hypertrophic Cardiomyopathy

Abstract

Physical activity presents an important cornerstone in the management and care of individuals with hypertrophic cardiomyopathy (HCM). Twenty-one individuals with HCM (age: 52±15 years old, body mass index (BMI): 30±7 kg/m²) completed 7-day monitoring using wrist-worn triaxial accelerometers (GENEActiv, ActivInsights Ltd, UK) and were compared to age and sex-matched healthy controls (age: 51±14 years old, BMI: 25±4 kg/m²). For individuals with HCM, clinical parameters (left atrial diameter and volume, peak oxygen consumption, NTproBNP and Minnesota Living with Heart Failure (MLHF)) were correlated with accelerometry. After adjusting for BMI, individuals with HCM spent less time in moderate-vigorous physical activity (MVPA) (86 (55–138) vs. 140 (121–149) minutes/day, p<0.05) compared to healthy controls. Individuals with HCM engaged in fewer MVPA-5 min (6 (2–15) vs. 27 (23–37) minutes/day, p<0.01) and MVPA-10 min bouts (9 (0–19) vs. 35 (17–54) minutes/day, p<0.01) versus healthy controls. For HCM only, peak oxygen consumption was correlated with MVPA (r=0.60, p<0.01) and MVPA-5 min bouts (r=0.47, p<0.05). MLHF score was correlated with sleep duration (r=0.45, p<0.05). Individuals with HCM should be encouraged to engage in moderate-intensity physical activity bouts and reduce prolonged periods of inactivity in order to potentially improve exercise tolerance and reduce disease burden.

Key words

myopathy - cardiology - physical activity - sleep

Publication History

Received: 10 November 2022

Accepted: 27 August 2023

Article published online:
27 October 2023

• References

• 1 Ommen SR, Mital S, Burke MA. et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation 2020; 142: e558-e631
• 2 Maron BJ. Hypertrophic cardiomyopathy: An important global disease. Am J Med 2004; 116: 63-65
• 3 Semsarian C, Ingles J, Maron MS. et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65: 1249-1254
• 4 Maron BJ, Casey SA, Poliac LC. et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281: 650-655
• 5 Bull FC, Al-Ansari SS, Biddle S. et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 2020; 54: 1451-1462
• 6 Gati S, Sharma S. Exercise prescription in individuals with hypertrophic cardiomyopathy: What clinicians need to know. Heart 2022; heartjnl 2021-319861
• 7 Lavie CJ, Ozemek C, Carbone S. et al. Sedentary behavior, exercise, and cardiovascular health. Circ Res 2019; 124: 799-815
• 8 Sweeting J, Ingles J, Timperio A. et al. Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers. Open Heart 2016; 3: e000484
• 9 Fumagalli C, Maurizi N, Day SM. et al. Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy. JAMA Cardiol 2020; 5: 65-72
• 10 Tafelmeier M, Baessler A, Wagner S. et al. Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy. Clin Cardiol 2020; 43: 430-440
• 11 Malay S, Chung KC. The choice of controls for providing validity and evidence in clinical research. Plast Reconst Surg 2012; 130: 959-965
• 12 van Hees VT, Gorzelniak L, Dean León EC. et al. Separating movement and gravity components in an acceleration signal and implications for the assessment of human daily physical activity. PloS one 2013; 8: e61691
• 13 Migueles JH, Rowlands AV, Huber F. et al. GGIR: A research community–driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data. J Meas Phys Behav 2019; 2: 188
• 14 RCoreTeam. R: A language and environment for statistical computing. R Foundation for Statistical Computing. (2021). In Internet: http://www.R-project.org/; (1 November 2022)
• 15 van Hees VT, Fang Z, Langford J. et al. Autocalibration of accelerometer data for free-living physical activity assessment using local gravity and temperature: An evaluation on four continents. J Appl Physiol 1985; 2014: 738-744
• 16 Charman SJ, van Hees VT, Quinn L. et al. The effect of percutaneous coronary intervention on habitual physical activity in older patients. BMC Cardiovasc Disord 2016; 16: 248
• 17 da Silva IC, van Hees VT, Ramires VV. et al. Physical activity levels in three Brazilian birth cohorts as assessed with raw triaxial wrist accelerometry. Int J Epidemiol 2014; 43: 1959-1968
• 18 Sabia S, van Hees VT, Shipley MJ. et al. Association between questionnaire- and accelerometer-assessed physical activity: The role of sociodemographic factors. Am J Epidemiol 2014; 179: 781-790
• 19 Cassidy S, Fuller H, Chau J. et al. Accelerometer-derived physical activity in those with cardio-metabolic disease compared to healthy adults: A UK Biobank study of 52,556 participants. Acta Diabetol 2018; 55: 975-979
• 20 Hildebrand M, Van Hees VT, Hansen BH. et al. Age-group comparability of raw accelerometer output from wrist-and hip-worn monitors. Med Sci Sports Exerc 2014; 46: 1816-1824
• 21 van Hees VT, Sabia S, Anderson KN. et al. A novel, open access method to assess sleep duration using a wrist-worn accelerometer. PLoS one 2015; 10: e0142533
• 22 Strath SJ, Holleman RG, Ronis DL. et al. Objective physical activity accumulation in bouts and nonbouts and relation to markers of obesity in US adults. Prev Chronic Dis 2008; 5: A131
• 23 Okwose NC, O’Brien N, Charman S. et al. Overcoming barriers to engagement and adherence to a home-based physical activity intervention for patients with heart failure: A qualitative focus group study. BMJ Open 2020; 10: e036382
• 24 Sweeting J, Ball K, McGaughran J. et al. Impact of the implantable cardioverter defibrillator on confidence to undertake physical activity in inherited heart disease: A cross-sectional study. Eur J Cardiovasc Nurs 2017; 16: 742-752
• 25 Saberi S, Wheeler M, Bragg-Gresham J. et al. Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: A randomized clinical trial. JAMA 2017; 317: 1349-1357
• 26 Kehler DS, Clara I, Hiebert B. et al. The association between patterns of physical activity and sedentary time with frailty in relation to cardiovascular disease. Aging Med (Milton) 2019; 2: 18-26
• 27 Kwon S, Lee HJ, Han KD. et al. Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): More physical activity is better. Br J Sports Med 2021; 55: 1034-1040
• 28 Sweeting J, Ingles J, Ball K. et al. A control theory-based pilot intervention to increase physical activity in patients with hypertrophic cardiomyopathy. Am J Cardiol 2018; 122: 866-871
• 29 Sweeting J, Ingles J, Ball K. et al. Daily step count as a simple marker of disease severity in hypertrophic cardiomyopathy. Heart Lung Circ 2018; 27: 752-755
• 30 Agarwal P, Shcherbina A, Day S. et al. Abstract 14963: Accelerometer-measured activity in non-obstructive hypertrophic cardiomyopathy: Patient-generated activity measures correlate with, and are convolutional neural network predictors of, clinical parameters in the MAVERICK-HCM Study. Circulation 2020; 142: A14963-A14963
• 31 Reineck E, Rolston B, Bragg-Gresham JL. et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol 2013; 111: 1034-1039
• 32 Pedrosa RP, Lima SG, Drager LF. et al. Sleep quality and quality of life in patients with hypertrophic cardiomyopathy. Cardiology 2010; 117: 200-206